Fresenius Medical Care KGAA ST
Healthcare · EUR · XETRA
Price
€37.32
Cap
€17.87B
Earnings
—
30d Trend
-3.5%
32% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 56×Macro 0.99 (−1%)=55
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
12-24 month value thesis — fundamentally underpriced
BRAIN47'S ASSESSMENT
I rate Fresenius Medical Care KGAA ST at 55/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 82/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-3.8%
3 MONTHS
-5.6%
12 MONTHS
-27.3%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
12-24 month value thesis — fundamentally underpriced. Fundamentals (82) and Quality (65) are the primary strengths. I note that momentum is the weakest area at 29/100 — this warrants monitoring. Historical volatility is moderate at 32%. I classify this as an income position — the 9.6% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.